Thrombolytic therapy for evolving myocardial infarction needs an approach that integrates benefit and risk.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/83FD6FCB.svg?ark=w1%2F20260515%2F83FD6FCB)](https://nobleid.org/work/w1/20260515/83FD6FCB)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors